BCL2 and gastric cancer: Further investigation including the histomorphological change of gastric cancer tissues and larger sample sizes will solidify the understanding of the mechanism underlying miR-1915-3p targeted inhibition to Bcl-2 in the pathogenesis of gastric cancer and exploring the potential therapeutic application of miR-1915-3p.